RNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032
The global RNA Therapeutics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global RNA Therapeutics market across By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings)
In the RNA Therapeutics market, the growing understanding of RNA biology and the development of RNA-based technologies are driving innovation in RNA therapeutics for the treatment of various diseases, including cancer, genetic disorders, and infectious diseases. RNA therapeutics encompass a range of approaches, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASOs), and RNA-based vaccines, aimed at modulating gene expression, correcting genetic defects, and stimulating immune responses. With the increasing demand for targeted and personalized therapies, there is a rising need for RNA therapeutics that offer improved delivery, stability, and specificity. Further, advancements in RNA synthesis, delivery vehicles, and nucleic acid chemistry are driving market growth by enabling more potent and efficient RNA-based therapies. By 2030, the market is expected to witness substantial expansion as pharmaceutical companies invest in RNA therapeutics to address unmet medical needs and capitalize on the therapeutic potential of RNA molecules.
RNA Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The RNA Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of RNA Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the RNA Therapeutics industry.
Key market trends defining the global RNA Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
RNA Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The RNA Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support RNA Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the RNA Therapeutics industry
Leading RNA Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 RNA Therapeutics companies.
RNA Therapeutics Market Study- Strategic Analysis Review
The RNA Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The RNA Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
RNA Therapeutics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America RNA Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various RNA Therapeutics market segments. Similarly, Strong market demand is encouraging Canadian RNA Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico RNA Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe RNA Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European RNA Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European RNA Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific RNA Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for RNA Therapeutics in Asia Pacific. In particular, China, India, and South East Asian RNA Therapeutics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America RNA Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa RNA Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East RNA Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for RNA Therapeutics.
RNA Therapeutics Market Company Profiles
The global RNA Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Alnylam Pharmaceuticals Inc, Arbutus Biopharma Corp, Arcturus Therapeutics Holdings Inc, Arrowhead Pharmaceuticals Inc, Astellas Pharma Inc, BioNTech SE, CRISPR Therapeutics AG, CureVac N.V., Ionis Pharmaceuticals Inc, Moderna Inc, Novartis AG, Orna Therapeutics, Pfizer Inc, Sanofi SA, Sarepta Therapeutics Inc, Silence Therapeutics plc, Sirnaomics Inc.
Recent RNA Therapeutics Market Developments
The global RNA Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
RNA Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Vaccines
Drugs
By Type
mRNA Therapeutics
RNA Interference (RNAi) Therapeutics
Antisense Oligonucleotide (ASO) Therapeutics
Others
By Indication
Infectious Diseases
Rare Genetic Diseases/Hereditary Diseases
Others
By End-User
Hospitals and Clinics
Research Settings
Geographical Segmentation:
Alnylam Pharmaceuticals Inc
Arbutus Biopharma Corp
Arcturus Therapeutics Holdings Inc
Arrowhead Pharmaceuticals Inc
Astellas Pharma Inc
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
Ionis Pharmaceuticals Inc
Moderna Inc
Novartis AG
Orna Therapeutics
Pfizer Inc
Sanofi SA
Sarepta Therapeutics Inc
Silence Therapeutics plc
Sirnaomics Inc
Formats Available: Excel, PDF, and PPT
In the RNA Therapeutics market, the growing understanding of RNA biology and the development of RNA-based technologies are driving innovation in RNA therapeutics for the treatment of various diseases, including cancer, genetic disorders, and infectious diseases. RNA therapeutics encompass a range of approaches, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASOs), and RNA-based vaccines, aimed at modulating gene expression, correcting genetic defects, and stimulating immune responses. With the increasing demand for targeted and personalized therapies, there is a rising need for RNA therapeutics that offer improved delivery, stability, and specificity. Further, advancements in RNA synthesis, delivery vehicles, and nucleic acid chemistry are driving market growth by enabling more potent and efficient RNA-based therapies. By 2030, the market is expected to witness substantial expansion as pharmaceutical companies invest in RNA therapeutics to address unmet medical needs and capitalize on the therapeutic potential of RNA molecules.
RNA Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The RNA Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of RNA Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the RNA Therapeutics industry.
Key market trends defining the global RNA Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
RNA Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The RNA Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support RNA Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the RNA Therapeutics industry
Leading RNA Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 RNA Therapeutics companies.
RNA Therapeutics Market Study- Strategic Analysis Review
The RNA Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The RNA Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
RNA Therapeutics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America RNA Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various RNA Therapeutics market segments. Similarly, Strong market demand is encouraging Canadian RNA Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico RNA Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe RNA Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European RNA Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European RNA Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific RNA Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for RNA Therapeutics in Asia Pacific. In particular, China, India, and South East Asian RNA Therapeutics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America RNA Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa RNA Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East RNA Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for RNA Therapeutics.
RNA Therapeutics Market Company Profiles
The global RNA Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Alnylam Pharmaceuticals Inc, Arbutus Biopharma Corp, Arcturus Therapeutics Holdings Inc, Arrowhead Pharmaceuticals Inc, Astellas Pharma Inc, BioNTech SE, CRISPR Therapeutics AG, CureVac N.V., Ionis Pharmaceuticals Inc, Moderna Inc, Novartis AG, Orna Therapeutics, Pfizer Inc, Sanofi SA, Sarepta Therapeutics Inc, Silence Therapeutics plc, Sirnaomics Inc.
Recent RNA Therapeutics Market Developments
The global RNA Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
RNA Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Vaccines
Drugs
By Type
mRNA Therapeutics
RNA Interference (RNAi) Therapeutics
Antisense Oligonucleotide (ASO) Therapeutics
Others
By Indication
Infectious Diseases
Rare Genetic Diseases/Hereditary Diseases
Others
By End-User
Hospitals and Clinics
Research Settings
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Alnylam Pharmaceuticals Inc
Arbutus Biopharma Corp
Arcturus Therapeutics Holdings Inc
Arrowhead Pharmaceuticals Inc
Astellas Pharma Inc
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
Ionis Pharmaceuticals Inc
Moderna Inc
Novartis AG
Orna Therapeutics
Pfizer Inc
Sanofi SA
Sarepta Therapeutics Inc
Silence Therapeutics plc
Sirnaomics Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 RNA Therapeutics Market Overview and Key Findings, 2024
1.2 RNA Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 RNA Therapeutics Market Growth Opportunities to 2030
1.4 Key RNA Therapeutics Market Trends and Challenges
1.4.1 RNA Therapeutics Market Drivers and Trends
1.4.2 RNA Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading RNA Therapeutics Companies
2. RNA THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 RNA Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 RNA Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. RNA THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. RNA THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Vaccines
Drugs
By Type
mRNA Therapeutics
RNA Interference (RNAi) Therapeutics
Antisense Oligonucleotide (ASO) Therapeutics
Others
By Indication
Infectious Diseases
Rare Genetic Diseases/Hereditary Diseases
Others
By End-User
Hospitals and Clinics
Research Settings
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific RNA Therapeutics Market, 2025
5.2 Asia Pacific RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe RNA Therapeutics Market, 2025
5.5 Europe RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America RNA Therapeutics Market, 2025
5.8 North America RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America RNA Therapeutics Market, 2025
5.11 South America Pacific RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa RNA Therapeutics Market, 2025
5.14 Middle East Africa RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa RNA Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US RNA Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US RNA Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada RNA Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico RNA Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany RNA Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France RNA Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK RNA Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain RNA Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy RNA Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe RNA Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China RNA Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India RNA Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan RNA Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea RNA Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia RNA Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia RNA Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific RNA Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil RNA Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina RNA Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America RNA Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East RNA Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa RNA Therapeutics Industry Drivers and Opportunities
7. RNA THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. RNA THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading RNA Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Alnylam Pharmaceuticals Inc
Arbutus Biopharma Corp
Arcturus Therapeutics Holdings Inc
Arrowhead Pharmaceuticals Inc
Astellas Pharma Inc
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
Ionis Pharmaceuticals Inc
Moderna Inc
Novartis AG
Orna Therapeutics
Pfizer Inc
Sanofi SA
Sarepta Therapeutics Inc
Silence Therapeutics plc
Sirnaomics Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 RNA Therapeutics Market Overview and Key Findings, 2024
1.2 RNA Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 RNA Therapeutics Market Growth Opportunities to 2030
1.4 Key RNA Therapeutics Market Trends and Challenges
1.4.1 RNA Therapeutics Market Drivers and Trends
1.4.2 RNA Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading RNA Therapeutics Companies
2. RNA THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 RNA Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 RNA Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. RNA THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. RNA THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Vaccines
Drugs
By Type
mRNA Therapeutics
RNA Interference (RNAi) Therapeutics
Antisense Oligonucleotide (ASO) Therapeutics
Others
By Indication
Infectious Diseases
Rare Genetic Diseases/Hereditary Diseases
Others
By End-User
Hospitals and Clinics
Research Settings
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific RNA Therapeutics Market, 2025
5.2 Asia Pacific RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe RNA Therapeutics Market, 2025
5.5 Europe RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America RNA Therapeutics Market, 2025
5.8 North America RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America RNA Therapeutics Market, 2025
5.11 South America Pacific RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America RNA Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa RNA Therapeutics Market, 2025
5.14 Middle East Africa RNA Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa RNA Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US RNA Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US RNA Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada RNA Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico RNA Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany RNA Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France RNA Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK RNA Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain RNA Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy RNA Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe RNA Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China RNA Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India RNA Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan RNA Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea RNA Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia RNA Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia RNA Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific RNA Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil RNA Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina RNA Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America RNA Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East RNA Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa RNA Therapeutics Industry Drivers and Opportunities
7. RNA THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. RNA THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading RNA Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Alnylam Pharmaceuticals Inc
Arbutus Biopharma Corp
Arcturus Therapeutics Holdings Inc
Arrowhead Pharmaceuticals Inc
Astellas Pharma Inc
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
Ionis Pharmaceuticals Inc
Moderna Inc
Novartis AG
Orna Therapeutics
Pfizer Inc
Sanofi SA
Sarepta Therapeutics Inc
Silence Therapeutics plc
Sirnaomics Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
